The spending has enabled the 81-year-old business to establish fully integrated capabilities spanning the entire drug lifecycle and world-leading expertise in HDAC6 biology. CKD is developing non ...

Pharmacological inhibition of HDAC6 and sirtuin 2 (SIRT2) activities increase acetylation of non-histone substrates, modulating cytoskeleton and microtubule dynamics and protein aggregation ...